Kerry Acquires Biothera and Wellmune Immune-Health Ingredient

Jennifer Grebow
Jennifer Grebow

Jennifer Grebow is the editor-in-chief of Nutritional Outlook, an award-winning media-content provider in the dietary supplement and natural products market. Nutritional Outlook, an MJH Life Sciences brand, provides insights and industry updates critical to manufacturers of dietary supplements, healthy foods, and nutritious beverages. Nutritional Outlook keeps industry abreast of current market trends, research updates, news, and regulatory developments. Nutritional Outlook goes beyond the 24-hour news cycle and provides in-depth analysis to help industry players navigate the challenges and changes in the near- and long-term. Nutritional Outlook is a brand of MJH Life Sciences, the largest privately held, independent, full-service medical media company in North America, dedicated to delivering trusted health care news across multiple channels.

Wellmune is used in both food and supplement products.

Food Ingredients and flavor firm Kerry Group plc (Tralee, Ireland) has acquired Biothera Inc. (Eagan, MN), a supplier best known for its trademark immune-health beta-glucan ingredient Wellmune. The ingredient is used in both food and supplement products.

“The addition of Wellmune to our portfolio offers Kerry tremendous growth opportunities globally,” said Michael O’Neill, Nutrition President, Kerry, in a press release. “This natural immunity enhancer strengthens our nutrition and general wellness capabilities and complements our taste solutions for applications in food, beverages, and supplements.”

“The combination of Biothera’s technology and Kerry’s leadership in R&D, nutritional science, and forward-looking market insights will advance the science of immune health and create new and innovative food, beverages, and supplements,” said Biothera CEO Richard G. Mueller.


Read more on Wellmune here


Jennifer Grebow
Nutritional Outlook magazine